About Prime Pharmaceuticals Private Limited
Data last updated:
Prime Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH1995PTC092543. Its GSTIN is 27AABCP6584G1Z5 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹61.84 Lakh. It was formerly known as Prime Pharmaceuticals Limited. It is led by directors including Devang Subodh Thakar and Manish Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 601 6th Floor Kamla Executive Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹148.64 Cr, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹8.78 Cr (net margin 5.9%) and EBITDA of ₹17.53 Cr (EBITDA margin 11.8%).
The company has about 46 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹85 Cr and satisfied charges of ₹17.35 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Gufic Biosciences Limited with revenue of ₹823.43 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website primepharma.com.
Company details
CIN history
Prime Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231MH1995PLC092543. The current CIN is U24231MH1995PTC092543, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH1995PTC092543 | Current |
| U24231MH1995PLC092543 | Previous |
Contact details
Prime Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is primepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address601 6th Floor Kamla Executive Park, A K Road Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Prime Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prime Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Prime Pharmaceuticals Private Limited, buy the company report.
Financials of Prime Pharmaceuticals Private Limited
FY 2025 filings availablePrime Pharmaceuticals Private Limited reported revenue of ₹148.64 Cr (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 131% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹148.64 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.53 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.78 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prime Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devang Subodh Thakar | Director | 02 Apr 1998 | 28 Years 6 Months | Current |
| Manish Patel | Director | 02 Apr 1998 | 28 Years 6 Months | Current |
| Manish Navnitrai Vora Also directs: Odon Prime Pharma Private Limited | Director | 23 May 2024 | 2 Years 5 Months | Current |
| Ramamurthy Ayyavuthevar | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
| Ashish Anil Vora Also directs: Regenix Biosciences Limited, Odon Prime Pharma Private Limited | Director | 11 Sep 1995 | 31 Years 1 Months | Current |
| Irfan Vazirally | Director | 20 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Prime Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gufic Biosciences Limited | ₹823.43 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Synokem Pharmaceuticals Limited | ₹791.15 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| SMS Pharmaceuticals Limited | ₹788.97 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Windlas Biotech Limited | ₹777.9 Cr (FY 2025) | 21.0% | Dehradun, Uttarakhand, India | |||
| Fourrts (India) Laboratories Private Limited | ₹760.55 Cr (FY 2024) | 7.0% | Chennai, Tamil Nadu, India | |||
| Pritam International Private Limited | ₹758.46 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Indchemie Health Specialities Private Limited | ₹734.44 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Sanofi-Synthelabo (India) Private Limited | ₹729.49 Cr (FY 2020) | 16.0% | Mumbai, Maharashtra, India | |||
| Prime Pharmaceuticals Private Limitedthis company | ₹148.64 Cr (FY 2025) | ₹8.78 Cr | 5.9% | 131.0% | 46 | Mumbai, Maharashtra, India |
To see the full peer comparison of Prime Pharmaceuticals Private Limited, buy the company report.
Auditor
Prime Pharmaceuticals Private Limited is audited by HEGDE & ASSOCIATES for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HEGDE & ASSOCIATES | FY 2025 | 103610W |
Shareholding
The shareholding of Prime Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prime Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2024 | 101014284 | Others | ₹20 Cr | Open | |
| 18 May 2023 | 100722743 | Citi Bank N.A. | ₹65 Cr | Open | |
| 17 Jul 2021 | 100463484 | Others | ₹50 Lakh | Satisfied | |
| 25 May 2021 | 100446854 | Others | ₹75 Lakh | Satisfied | |
| 06 May 2017 | 100115789 | Others | ₹10.5 Cr | Satisfied |
To see the full charge records of Prime Pharmaceuticals Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Prime Pharmaceuticals Private Limited has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Sep 2022 | Rights issue | ₹10 Lakh | Investors: 3 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
To see the full deal history of Prime Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Prime Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Prime Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Commercial suit | Filed by the company against Ambalal Sarabhai Enterprises Ltd. | Disposed |
| High Court, GUJARAT | Commercial suit | Filed by the company against M/S Synbiotics Ltd. and 1 other | Disposed |
| High Court, GUJARAT | Court case (COMP) | Filed by the company against M/S. Ambalal Sarabhai Enterprises Ltd. | Disposed |
To see the full case history of Prime Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Prime Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Chase Logistics Private Limited | |||
| an individual supplier | |||
| Macro Logistics & Exim Private Limited | |||
| an individual supplier | |||
| Dhruvi Offset |
To see the full MSME payment records of Prime Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Prime Pharmaceuticals Private Limited has a workforce of 46 employees on its EPFO records as of Jan 09, 2026, across 1 active EPFO establishment.
GST
Prime Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCP6584G1Z5 | Maharashtra | Active | 01 Jul 2017 |
| 24AABCP6584G1ZB | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Prime Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prime Pharmaceuticals Private Limited has 10 board changes on record since 1995: 6 appointments and 4 cessations. The latest: Manish Navnitrai Vora ceased to be Additional Director on 29 Sep 2024.
38 earlier events are in the company report.
Frequently asked questions
Prime Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 1995 (31+ years old) and is registered under CIN U24231MH1995PTC092543.
Prime Pharmaceuticals has 6 current directors:
- Devang Subodh Thakar - Director
- Manish Patel - Director
- Manish Navnitrai Vora - Director
- Ramamurthy Ayyavuthevar - Director
- Ashish Anil Vora - Director
- Irfan Vazirally - Director
The latest financial statements of Prime Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prime Pharmaceuticals is 27AABCP6584G1Z5, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCP6584G1ZB (Gujarat).
The CIN (Corporate Identification Number) of Prime Pharmaceuticals is U24231MH1995PTC092543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prime Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Prime Pharmaceuticals was incorporated on 11 September 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Prime Pharmaceuticals has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023.
The peers of Prime Pharmaceuticals by revenue are Gufic Biosciences Limited, Synokem Pharmaceuticals Limited, SMS Pharmaceuticals Limited, Windlas Biotech Limited, Fourrts (India) Laboratories Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manish Navnitrai Vora ceased to be Additional Director on 29 Sep 2024. Manish Navnitrai Vora was appointed as Director on 23 May 2024. Ramamurthy Ayyavuthevar ceased to be Additional Director on 30 Sep 2022. Prime Pharmaceuticals has 10 board changes on record in total.
Prime Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers. The latest return was filed on 02 Jul 2024.
Prime Pharmaceuticals can be reached through the website primepharma.com. Its registered office is in Mumbai, Maharashtra, India.